BridgeMD
New treatment option for Ventral Hernia
Official title Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
ClinicalTrials.gov ID: NCT07226791
What this study is testing
What is AGN-151607-DP?
AGN-151607-DP is an investigational medicine, given as an once-weekly injection into a muscle, being studied as a potential treatment for ventral hernia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A ventral hernia happens when the muscles in the front of your belly become weak and let organs push through, causing a bulge. If it gets worse, intestines can slip into the bulge, leading to serious pain and health problems.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- \- Midline ventral hernia requiring open surgical repair.
You likely can't join if
- Medical condition that may put the participant at increased risk with exposure to AGN-151607-DP, including diagnosed muscular dystrophy (e.g...
- History of abdominal or hernia repair surgery requiring hospitalization within 6 months prior to screening.
The study team makes the final eligibility decision.
Where it's taking place
- Riverside, California, United States
- Jacksonville, Florida, United States
- Miami, Florida, United States
- Pensacola, Florida, United States
- Evanston, Illinois, United States
- Wichita, Kansas, United States
- Wilmington, North Carolina, United States
- Cleveland, Ohio, United States
- Greenville, South Carolina, United States
- Dallas, Texas, United States
- Roanoke, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Riverside, California, United States; Jacksonville, Florida, United States; Miami, Florida, United States; Pensacola, Florida, United States; Evanston, Illinois, United States; Wichita, Kansas, United States and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.